Date : Wednesday, 04 November 2026
Start Time : 08:30
End Time : 10:30
Location : Main Hall
GI3
Presentations
08:30 | LI-RADS Treatment Response: How To Report HCC Viability After Locoregional Therapies (Ablation/TACE).
Cu
08:50 | Borderline Lesions In The Cirrhotic Liver: Imaging The Stepwise Carcinogenesis. Distinguishing Regenerative Nodules Vs. Dysplastic Nodules Vs. Early HCC.
Cu
09:15 | Intrahepatic Cholangiocarcinoma: Differentiating Mass-forming CCA From HCC And Mixed HCC-CCA, Staging Pearls
Cu
09:40 | Liver Metastases: Assessing "treatment Response" Post-chemotherapy And The Concept Of Pseudocirrhosis
Cu
10:00 | Interventional Management Of Hepatic Metastases: A Guide For Patient Selection And Interventional Procedure
Cu